+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Migraine Market Report 2026 - Product Thumbnail Image

Migraine Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Migraine Treatment Market Report 2026 - Product Thumbnail Image

Migraine Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
From
Bispecific Antibodies Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bispecific Antibodies Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
US Biosimilar industry outlook to 2028 - Product Thumbnail Image

US Biosimilar industry outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Ankylosing Spondylitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ankylosing Spondylitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Gynecological Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Gynecological Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 198 Pages
  • Global
From
Systemic Lupus Erythematosus - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
From
From
Loading Indicator